EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring Lead-Like Molecules of Traditional Chinese Medicine for Treatment Quest against Aliarcobacter butzleri: In Silico Toxicity Assessment, Dynamics Simulation, and Pharmacokinetic Profiling

Zarrin Basharat iD, Ibrar Ahmed iD, Sulaiman Mohammed Alnasser iD, Alotaibi Meshal iD, Yasir Waheed iD

BioMed Research International · 2024

DOI: 10.1155/2024/9377016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioMed Research International, 2024. Verfasst von Zarrin Basharat und 4 weiteren Autor:innen. Beteiligte Einrichtung: Alpha Genomics (Private) Limited, Islamabad 45710, Pakistan. Hauptthemen laut MEDLINE: Medicine, Chinese Traditional, Molecular Docking Simulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qassim University, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Aliarcobacter butzleri is a Gram-negative, curved or spiral-shaped, microaerophilic bacterium and causes human infections, specifically diarrhea, fever, and sepsis. The research objective of this study was to employ computer-aided drug design techniques to identify potential natural product inhibitors of a vital enzyme in this bacterium. The pyrimidine biosynthesis pathway in its core genome fraction is crucial for its survival and presents a potential target for novel therapeutics. Hence, novel small molecule inhibitors were identified (from traditional Chinese medicinal (TCM) compound library) against it, which may be used for possible curbing of infection by A. butzleri.

Methods

A comprehensive subtractive genomics approach was utilized to identify a key enzyme (orotidine- 5 ′ -phosphate decarboxylase) cluster conserved in the core genome fraction of A. butzleri. It was selected for inhibitor screening due to its vital role in pyrimidine biosynthesis. TCM library ( n > 36,000 compounds) was screened against it using pharmacophore model based on orotidylic acid (control), and the obtained lead-like molecules were subjected to structural docking using AutoDock Vina. The top-scoring compounds, ZINC70454134, ZINC85632684, and ZINC85632721, underwent further scrutiny via a combination of physiological-based pharmacokinetics, toxicity assessment, and atomic-scale dynamics simulations (100 ns).

Results

Among the screened compounds, ZINC70454134 displayed the most favorable characteristics in terms of binding, stability, absorption, and safety parameters. Overall, traditional Chinese medicine (TCM) compounds exhibited high bioavailability, but in diseased states (cirrhosis, renal impairment, and steatosis), there was a significant decrease in absorption, Cmax, and AUC of the compounds compared to the healthy state. Furthermore, MD simulation demonstrated that the ODCase-ZINC70454134 complex had a superior overall binding affinity, supported by PCA proportion of variance and eigenvalue rank analysis. These favorable characteristics underscore its potential as a promising drug candidate.

Conclusion

The computer-aided drug design approach employed for this study helped expedite the discovery of antibacterial compounds against A. butzleri, offering a cost-effective and efficient approach to address infection by it. It is recommended that ZINC70454134 should be considered for further experimental analysis due to its indication as a potential therapeutic agent for combating A. butzleri infections. This study provides valuable insights into the molecular basis of biophysical inhibition of A. butzleri through TCM compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medicine, Chinese TraditionalMolecular Docking SimulationHumansMolecular Dynamics SimulationDrugs, Chinese HerbalAnti-Bacterial AgentsComputer Simulation

Substanzen

Drugs, Chinese HerbalAnti-Bacterial Agents

Autor:innen und Institutionen

  • Alpha Genomics (Private) Limited, Islamabad 45710, Pakistan.
  • Group of Biometrology, The Korea Research Institute of Standards and Science (KRISS), Yuseong District, Daejeon 34113, Republic of Korea.
  • Department of Pharmacology and Toxicology, Unaizah College of Pharmacy, Qassim University, Buraydah 52571, Saudi Arabia.
  • Department of Pharmacy Practice, College of Pharmacy, University of Hafr Al Batin, Hafar Al Batin, Saudi Arabia.
  • Office of Research, Innovation and Commercialization (ORIC), Shaheed Zulfiqar Ali Bhutto Medical University (SZABMU), Islamabad 44000, Pakistan.
  • Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos 1401, Lebanon.

ORCID-Profile: Zarrin Basharat, Ibrar Ahmed, Sulaiman Mohammed Alnasser, Alotaibi Meshal, Yasir Waheed

Förderung

  • Qassim University
  • National Research Foundation of Korea

Zitieren

APA

Basharat, Z., Ahmed, I., Alnasser, S. M., Meshal, A., & Waheed, Y. (2024). Exploring Lead-Like Molecules of Traditional Chinese Medicine for Treatment Quest against Aliarcobacter butzleri: In Silico Toxicity Assessment, Dynamics Simulation, and Pharmacokinetic Profiling. BioMed Research International. https://doi.org/10.1155/2024/9377016

Vancouver

Basharat Z, Ahmed I, Alnasser SM, Meshal A, Waheed Y. Exploring Lead-Like Molecules of Traditional Chinese Medicine for Treatment Quest against Aliarcobacter butzleri: In Silico Toxicity Assessment, Dynamics Simulation, and Pharmacokinetic Profiling. BioMed Research International. 2024. doi:10.1155/2024/9377016

BibTeX
@article{Basharat2024,
  author = {Basharat, Zarrin and Ahmed, Ibrar and Alnasser, Sulaiman Mohammed and Meshal, Alotaibi and Waheed, Yasir},
  title = {Exploring Lead-Like Molecules of Traditional Chinese Medicine for Treatment Quest against Aliarcobacter butzleri: In Silico Toxicity Assessment, Dynamics Simulation, and Pharmacokinetic Profiling},
  journal = {BioMed Research International},
  year = {2024},
  doi = {10.1155/2024/9377016}
}
Kostenlos starten →